Company profile

Medasense Biometrics Ltd.

Medasense Biometrics Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on February 17, 2023 and the most recent on February 17, 2023 (PMD-200). Its most common review panel is Anesthesiology (1 device).

1AI devices
2023First decision
2023Latest decision
1Specialties

Timeline

  1. PMD-200 · Anesthesiology · QVE